Who owns ASCENDIS PHARMA A/S?
- CUSIP Number: 04351pad3
Tip: Access positions for across all investors
Analyze quarterly positions in Ascendis Pharma A/s with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Ascendis Pharma A/s stock
Who bought or sold ASCENDIS PHARMA A/S this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Linden Advisors | 137M | $195M | -5% | Dec 2025 |
|
| Wolverine Asset Management | 79M | $113M | -15% | Dec 2025 |
|
| Franklin Resources | 47M | $67M | 0% | Dec 2025 |
|
| Lazard Asset Management | 35M | $500k | 0% | Dec 2025 |
|
| DeepCurrents Investment Group | 33M | $47M | 29% | Dec 2025 |
|
| Capstone Investment Advisors | 26M | $37M | 45% | Dec 2025 |
|
| Point72 Asset Management | 20M | $28M | 0% | Dec 2025 |
|
| State Street Corporation | 12M | $18M | 2% | Dec 2025 |
|
| Partner Fund Management | 12M | $16M | -50% | Sep 2025 |
|
| SSI Investment Management | 11M | $15M | 11% | Dec 2025 |
|
| Davidson Kempner Capital Management | 10M | $14M | -44% | Dec 2025 |
|
| BlackRock | 7.3M | $10M | 32% | Dec 2025 |
|
| Ameriprise Financial | 6.5M | $9.2M | 18% | Dec 2025 |
|
| Nicholas Investments Partners | 6.0M | $8.5M | 0% | Dec 2025 |
|
| Polar Capital Holdings | 5.0M | $7.1M | 0% | Dec 2025 |
|
| Lombard Odier Asset Management | 4.2M | $5.9M | 1870% | Dec 2025 |
|
| DAFNA Capital Management | 4.0M | $5.5M | 0% | Dec 2025 |
|
| Invesco | 3.0M | $4.3M | 50% | Dec 2025 |
|
| State of Wisconsin Investment Board | 3.0M | $4.3M | 0% | Dec 2025 |
|
| Bnp Paribas Investment Partners | 2.0M | $2.8M | 0% | Dec 2025 |
|
| Bnp Paribas Arbitrage, Snc | 1.8M | $2.5M | 79% | Dec 2025 |
|
| Ing Investment Management | 1.7M | $2.4M | 0% | Dec 2025 |
|
| Leucadia National Corporation | 1.6M | $2.2M | 10% | Dec 2025 |
|
| Millennium Management | 1.5M | $2.0M | 0% | Sep 2025 |
|
| Barclays | 1.4M | $1.9M | 100% | Dec 2025 |
|
| Royal Bank of Canada | 1.2M | $1.6M | -36% | Sep 2025 |
|
| Man Group | 1.2M | $1.6M | -32% | Dec 2025 |
|
| Zazove Associates | 1.1M | $1.4M | -86% | Sep 2025 |
|
| Oaktree Capital Management | 1.0M | $1.4M | -23% | Sep 2025 |
|
| RWC Asset Management | 970k | $1.4M | -35% | Dec 2025 |
|
| Groupama Asset Managment | 700k | $987k | 100% | Dec 2025 |
|
| Union Bancaire Privee, UBP SA | 520k | $623k | 0% | Dec 2025 |
|
| Central Pacific Bank - Trust Division | 458k | $649k | 33% | Dec 2025 |
|
| Jpmorgan Chase & Co | 458k | $607k | 100% | Sep 2025 |
|
| Shenkman Capital Management | 439k | $626M | -86% | Dec 2025 |
|
| Deutsche Bank Aktiengesellschaft | 375k | $531k | 0% | Dec 2025 |
|
| Wells Fargo & Company | 350k | $488k | 100% | Dec 2025 |
|
| Bank of New York Mellon | 200k | $279k | -33% | Dec 2025 |
|
| SG Americas Securities | 180k | $25M | 0% | Dec 2025 |
|
| Russell Investments | 180k | $256k | 0% | Dec 2025 |
|
| Virtus ETF Advisers | 32k | $45k | 100% | Dec 2025 |
|
| Loomis, Sayles and | 18k | $3.8M | 100% | Dec 2025 |
|
| Boussard & Gavaudan Investment Management | 8.5k | $12M | 100% | Dec 2025 |
|
| Oddo Bhf Asset Management Sas | 161.00 | $230k | 100% | Dec 2025 |
|
Who sold out of Ascendis Pharma A/s?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Opti Capital Management | Sep 2025 | 21M | $29B |
| Tenor Capital Management | Jun 2025 | 7.3M | $9.1M |
| CSS | Sep 2025 | 4.4M | $6.0M |
| Jane Street | Sep 2025 | 450k | $616k |